Opportunities and Challenges of Implementing Pharmacogenomics in Cancer Drug Development

doi 10.20517/cdr.2018.22
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OAE Publishing Inc.

Related search

Pharmacogenomics: Challenges and Opportunities

Annals of Internal Medicine
Internal MedicineMedicine
2006English

Drug Development and Registration: Challenges and Opportunities in Ovarian Cancer

Cancer
Cancer ResearchOncology
2017English

Pharmacogenomics in Clinical Practice and Drug Development

Nature Biotechnology
Applied MicrobiologyBiotechnologyBiomedical EngineeringMolecular MedicineBioengineering
2012English

Orphan Drug Development in China ‒ Turning Challenges Into Opportunities

Intractable and Rare Diseases Research
Medicine
2016English

Pharmacogenomics in Clinical Practice and Drug Development

Nature Biotechnology
Applied MicrobiologyBiotechnologyBiomedical EngineeringMolecular MedicineBioengineering
2012English

Pharmacogenomics: Activating Cancer Drug Discovery

Environmental Health Perspectives
MutagenesisPublic HealthEnvironmentalHealthToxicologyOccupational Health
2004English

Pharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next Decade

OMICS A Journal of Integrative Biology
GeneticsMolecular BiologyBiochemistryMolecular MedicineMedicineBiotechnology
2016English

“Personalizing” Academic Medicine: Opportunities and Challenges in Implementing Genomic Profiling

Translational Research
BiochemistryPublic HealthEnvironmentalMedicinePhysiologyOccupational Health
2009English

Opportunities and Challenges of Implementing Predictive Analytics for Competitive Advantage

International Journal of Business Intelligence Research
StatisticsProbabilityUncertaintyInformation SystemsManagementManagement Information Systems
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy